Trial Profile
An open, multicenter, non-comparative, phase IV trial of efficacy and safety of Ketek (telithromycin) 800mg.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Oct 2009
Price :
$35
*
At a glance
- Drugs Telithromycin (Primary)
- Indications Acute exacerbations of chronic bronchitis; Acute sinusitis; Bacterial infections; Community-acquired pneumonia
- Focus Therapeutic Use
- Sponsors Sanofi
- 15 Sep 2006 New trial record.